Aethlon Net Receivables vs Other Current Assets Analysis

AEMD Stock

USD 1.36 0.14 9.33%

Aethlon Medical financial indicator trend analysis is way more than just evaluating Aethlon Medical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aethlon Medical is a good investment. Please check the relationship between Aethlon Medical Net Receivables and its Other Current Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.

Net Receivables vs Other Current Assets

Net Receivables vs Other Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aethlon Medical Net Receivables account and Other Current Assets. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Aethlon Medical's Net Receivables and Other Current Assets is 0.19. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Other Current Assets in the same time period over historical financial statements of Aethlon Medical, assuming nothing else is changed. The correlation between historical values of Aethlon Medical's Net Receivables and Other Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Aethlon Medical are associated (or correlated) with its Other Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Assets has no effect on the direction of Net Receivables i.e., Aethlon Medical's Net Receivables and Other Current Assets go up and down completely randomly.

Correlation Coefficient

0.19

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Net Receivables

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Most indicators from Aethlon Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aethlon Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.At present, Aethlon Medical's Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 0.44, whereas Sales General And Administrative To Revenue is forecasted to decline to 12.03.

Aethlon Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Property Plant And Equipment Net	Accounts Payable	Property Plant And Equipment Gross	Intangible Assets	Short Long Term Debt Total	Current Deferred Revenue	Other Assets	Net Receivables	Inventory	Other Current Assets
Total Assets		-0.29	-0.34	0.9	-0.94	-0.79	1.0	0.89	0.86	1.0	-0.4	0.94	0.92	-0.24	1.0	-0.32	0.89	-0.02	0.89	-0.89	-0.27	-0.41	0.13	-0.48	-0.87	0.13
Other Current Liab	-0.29		0.95	-0.66	0.41	0.23	-0.31	-0.18	-0.19	-0.31	0.93	-0.24	-0.33	0.95	-0.3	0.93	-0.2	0.42	-0.2	0.46	0.69	0.85	-0.11	0.2	0.3	-0.12
Total Current Liabilities	-0.34	0.95		-0.71	0.5	0.29	-0.36	-0.19	-0.22	-0.36	0.98	-0.25	-0.38	0.99	-0.35	0.98	-0.21	0.58	-0.21	0.55	0.86	0.97	0.01	0.38	0.34	-0.17
Total Stockholder Equity	0.9	-0.66	-0.71		-0.94	-0.72	0.91	0.74	0.74	0.91	-0.75	0.81	0.85	-0.64	0.91	-0.7	0.75	-0.28	0.75	-0.92	-0.6	-0.75	0.09	-0.52	-0.82	0.2
Net Debt	-0.94	0.41	0.5	-0.94		0.81	-0.96	-0.72	-0.84	-0.96	0.55	-0.82	-0.86	0.43	-0.96	0.49	-0.72	0.2	-0.72	0.9	0.48	0.57	-0.03	0.48	0.89	-0.28
Retained Earnings	-0.79	0.23	0.29	-0.72	0.81		-0.8	-0.62	-0.72	-0.8	0.34	-0.69	-0.93	0.23	-0.8	0.29	-0.6	0.23	-0.6	0.58	0.31	0.41	0.44	0.37	0.78	-0.25
Cash	1.0	-0.31	-0.36	0.91	-0.96	-0.8		0.85	0.85	1.0	-0.42	0.92	0.92	-0.27	1.0	-0.35	0.85	-0.06	0.85	-0.89	-0.31	-0.43	0.1	-0.48	-0.88	0.17
Non Current Assets Total	0.89	-0.18	-0.19	0.74	-0.72	-0.62	0.85		0.79	0.85	-0.25	0.96	0.83	-0.08	0.85	-0.16	1.0	0.18	1.0	-0.8	-0.06	-0.25	0.27	-0.53	-0.69	-0.15
Non Currrent Assets Other	0.86	-0.19	-0.22	0.74	-0.84	-0.72	0.85	0.79		0.85	-0.28	0.86	0.75	-0.16	0.86	-0.23	0.78	0.08	0.78	-0.79	-0.15	-0.27	0.18	-0.4	-0.79	0.0
Cash And Short Term Investments	1.0	-0.31	-0.36	0.91	-0.96	-0.8	1.0	0.85	0.85		-0.42	0.92	0.92	-0.27	1.0	-0.35	0.85	-0.06	0.85	-0.89	-0.31	-0.43	0.1	-0.48	-0.88	0.17
Common Stock Total Equity	-0.4	0.93	0.98	-0.75	0.55	0.34	-0.42	-0.25	-0.28	-0.42		-0.32	-0.43	0.97	-0.41	0.99	-0.27	0.59	-0.27	0.59	0.83	0.97	0.0	0.34	0.41	-0.18
Common Stock Shares Outstanding	0.94	-0.24	-0.25	0.81	-0.82	-0.69	0.92	0.96	0.86	0.92	-0.32		0.87	-0.15	0.92	-0.23	0.96	0.14	0.96	-0.85	-0.15	-0.31	0.27	-0.49	-0.83	0.07
Other Stockholder Equity	0.92	-0.33	-0.38	0.85	-0.86	-0.93	0.92	0.83	0.75	0.92	-0.43	0.87		-0.28	0.91	-0.36	0.82	-0.15	0.82	-0.75	-0.33	-0.48	-0.2	-0.5	-0.82	0.15
Total Liab	-0.24	0.95	0.99	-0.64	0.43	0.23	-0.27	-0.08	-0.16	-0.27	0.97	-0.15	-0.28		-0.26	0.98	-0.1	0.6	-0.1	0.47	0.86	0.95	0.02	0.3	0.29	-0.21
Total Current Assets	1.0	-0.3	-0.35	0.91	-0.96	-0.8	1.0	0.85	0.86	1.0	-0.41	0.92	0.91	-0.26		-0.34	0.85	-0.05	0.85	-0.89	-0.3	-0.42	0.1	-0.47	-0.88	0.17
Common Stock	-0.32	0.93	0.98	-0.7	0.49	0.29	-0.35	-0.16	-0.23	-0.35	0.99	-0.23	-0.36	0.98	-0.34		-0.17	0.63	-0.17	0.53	0.84	0.97	0.03	0.29	0.36	-0.21
Property Plant And Equipment Net	0.89	-0.2	-0.21	0.75	-0.72	-0.6	0.85	1.0	0.78	0.85	-0.27	0.96	0.82	-0.1	0.85	-0.17		0.17	1.0	-0.82	-0.08	-0.27	0.29	-0.54	-0.69	-0.15
Accounts Payable	-0.02	0.42	0.58	-0.28	0.2	0.23	-0.06	0.18	0.08	-0.06	0.59	0.14	-0.15	0.6	-0.05	0.63	0.17		0.17	0.14	0.61	0.68	0.48	0.27	0.11	-0.21
Property Plant And Equipment Gross	0.89	-0.2	-0.21	0.75	-0.72	-0.6	0.85	1.0	0.78	0.85	-0.27	0.96	0.82	-0.1	0.85	-0.17	1.0	0.17		-0.82	-0.08	-0.27	0.29	-0.54	-0.69	-0.15
Intangible Assets	-0.89	0.46	0.55	-0.92	0.9	0.58	-0.89	-0.8	-0.79	-0.89	0.59	-0.85	-0.75	0.47	-0.89	0.53	-0.82	0.14	-0.82		0.47	0.61	-0.32	0.68	0.82	-0.06
Short Long Term Debt Total	-0.27	0.69	0.86	-0.6	0.48	0.31	-0.31	-0.06	-0.15	-0.31	0.83	-0.15	-0.33	0.86	-0.3	0.84	-0.08	0.61	-0.08	0.47		0.91	0.24	0.42	0.33	-0.39
Current Deferred Revenue	-0.41	0.85	0.97	-0.75	0.57	0.41	-0.43	-0.25	-0.27	-0.43	0.97	-0.31	-0.48	0.95	-0.42	0.97	-0.27	0.68	-0.27	0.61	0.91		0.14	0.48	0.42	-0.21
Other Assets	0.13	-0.11	0.01	0.09	-0.03	0.44	0.1	0.27	0.18	0.1	0.0	0.27	-0.2	0.02	0.1	0.03	0.29	0.48	0.29	-0.32	0.24	0.14		-0.03	-0.07	-0.21
Net Receivables	-0.48	0.2	0.38	-0.52	0.48	0.37	-0.48	-0.53	-0.4	-0.48	0.34	-0.49	-0.5	0.3	-0.47	0.29	-0.54	0.27	-0.54	0.68	0.42	0.48	-0.03		0.44	0.19
Inventory	-0.87	0.3	0.34	-0.82	0.89	0.78	-0.88	-0.69	-0.79	-0.88	0.41	-0.83	-0.82	0.29	-0.88	0.36	-0.69	0.11	-0.69	0.82	0.33	0.42	-0.07	0.44		-0.4
Other Current Assets	0.13	-0.12	-0.17	0.2	-0.28	-0.25	0.17	-0.15	0.0	0.17	-0.18	0.07	0.15	-0.21	0.17	-0.21	-0.15	-0.21	-0.15	-0.06	-0.39	-0.21	-0.21	0.19	-0.4

Click cells to compare fundamentals

Aethlon Medical Account Relationship Matchups

Aethlon Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	10.4M	10.7M	19.4M	17.5M	20.1M	21.1M
Other Current Liab	584.1K	880.2K	852.6K	588.6K	676.9K	643.0K
Total Current Liabilities	1.1M	1.4M	1.8M	1.5M	1.7M	1.6M
Total Stockholder Equity	9.4M	9.4M	17.1M	15.1M	17.3M	18.2M
Net Debt	(9.5M)	(9.8M)	(16.3M)	(13.3M)	(12.0M)	(11.4M)
Retained Earnings	(112.0M)	(119.9M)	(130.3M)	(142.4M)	(128.1M)	(121.7M)
Cash	9.6M	9.9M	17.1M	14.5M	16.7M	17.5M
Non Current Assets Total	346.6K	317.2K	1.3M	2.4M	2.8M	2.9M
Cash And Short Term Investments	9.6M	9.9M	17.1M	14.5M	16.7M	17.5M
Common Stock Total Equity	17.7K	19.0K	9.4K	12.2K	14.0K	13.3K
Common Stock Shares Outstanding	341.5K	1.2M	1.5M	2.1M	2.4M	2.5M
Liabilities And Stockholders Equity	10.4M	10.7M	19.4M	17.5M	20.1M	21.1M
Other Stockholder Equity	121.4M	129.3M	147.4M	163.5M	188.1M	197.5M
Total Liab	1.1M	1.4M	2.4M	2.4M	2.8M	4.1M
Total Current Assets	10.0M	10.4M	18.2M	15.1M	17.4M	18.2M
Common Stock	9.4K	12.2K	15.4K	23.0K	26.4K	39.5K
Property Plant And Equipment Net	276.9K	201.3K	1.1M	2.3M	2.6M	2.8M
Accounts Payable	285.0K	337.7K	500.0K	432.9K	389.6K	563.8K
Property Plant And Equipment Gross	276.9K	201.3K	1.1M	2.3M	2.6M	2.8M
Intangible Assets	57.5K	57.0K	2.2K	1.7K	1.5K	1.4K
Short Long Term Debt Total	141.1K	42.5K	729.4K	1.2M	1.1M	936.2K
Other Current Assets	229.6M	341.1M	956.6K	557.6K	641.3K	609.2K
Accumulated Other Comprehensive Income	(368.3K)	(385.5K)	0.0	(6.1M)	(5.5M)	(5.3M)
Short Term Debt	98.6K	42.5K	126.9K	269.4K	242.4K	230.3K
Property Plant Equipment	140.5K	201.3K	1.1M	2.3M	2.6M	2.8M
Non Current Liabilities Total	42.5K	495.1K	602.5K	939.6K	1.1M	1.1M
Net Tangible Assets	9.4M	9.4M	17.1M	15.1M	17.3M	18.2M
Noncontrolling Interest In Consolidated Entity	(101.2K)	(126.0K)	(132.1K)	(136.9K)	(123.2K)	(117.1K)
Retained Earnings Total Equity	(99.5M)	(105.7M)	(112.0M)	(119.9M)	(107.9M)	(113.3M)
Capital Surpluse	105.6M	108.1M	121.4M	129.3M	148.7M	97.7M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Aethlon Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Aethlon Medical's short interest history, or implied volatility extrapolated from Aethlon Medical options trading.

Pair Trading with Aethlon Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aethlon Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aethlon Medical will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aethlon Stock

0.67

Guardant Health Financial Report 14th of May 2024

Pair Corr

Moving against Aethlon Stock

0.74	ELYM	Eliem Therapeutics Upward Rally	Pair Corr
0.56	ACB	Aurora Cannabis Sell-off Trend	Pair Corr
0.45	HCWB	HCW Biologics	Pair Corr

The ability to find closely correlated positions to Aethlon Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aethlon Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aethlon Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aethlon Medical to buy it.

The correlation of Aethlon Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aethlon Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aethlon Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Aethlon Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports:

How To Invest In Aethlon

Details

Is Aethlon Stock a good investment?

Details

What is Aethlon Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.

You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Aethlon Stock analysis

When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.

	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules

Is Aethlon Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(5.01)

Revenue Per Share

0.236

Quarterly Revenue Growth

42.782

Return On Assets

(0.47)

Return On Equity

(0.98)

The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Aethlon Net Receivables vs Other Current Assets Analysis

Net Receivables vs Other Current Assets

Net Receivables vs Other Current Assets Correlation Analysis

Correlation Coefficient

Net Receivables

Other Current Assets

Aethlon Medical fundamental ratios Correlations

Aethlon Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Aethlon Medical fundamental ratios Accounts

Pair Trading with Aethlon Medical

Moving together with Aethlon Stock

Moving against Aethlon Stock

Complementary Tools for Aethlon Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Property Plant And Equipment Net	+ 1.0	Non Current Assets Total

Total Current Assets	- 0.96	Net Debt
Cash And Short Term Investments	- 0.96	Net Debt
Cash	- 0.96	Net Debt
Net Debt	- 0.94	Total Stockholder Equity
Net Debt	- 0.94	Total Assets
Other Stockholder Equity	- 0.93	Retained Earnings